Literature DB >> 8089316

Quantitative metabolite patterns of human brain tumors: detection by 1H NMR spectroscopy in vivo and in vitro.

J P Usenius1, R A Kauppinen, P A Vainio, J A Hernesniemi, M P Vapalahti, L A Paljärvi, S Soimakallio.   

Abstract

OBJECTIVE: The aim of the present study was to investigate quantitative metabolite patterns in human brain tumors by 1H nuclear MR spectroscopy (1H MRS).
MATERIALS AND METHODS: Single voxel 1H MRS was used in studying metabolites in 23 primary brain tumors in vivo. The T2 relaxation times and saturation factors were determined for N-acetylaspartate (NAA), total creatine (Cr), choline-containing compounds (Cho), and water, which was used as an internal standard in computations of metabolite concentrations in vivo. Metabolites in biopsy specimens from 75 tumors were quantified by means of 1H MRS in vitro.
RESULTS: The NAA concentrations were lower in brain tumors than in normal tissue in vitro and in vivo, irrespective of the histological type. The NAA was some threefold higher in vivo than in vitro, which could be due to partial volume effect and/or contributions from other metabolites to the peak at 2.02 ppm in vivo. Ratios of Cho to Cr concentrations were elevated in tumors relative to normal brain in vivo. Absolute Cho was some 50% higher in both benign astrocytomas and oligodendrogliomas in vivo than in normal brain. However, Cho concentration in vitro was significantly higher only in pituitary adenomas than in healthy white matter. Total creatine was approximately 50% lower in malignant astrocytomas and meningiomas than in normal brain.
CONCLUSION: It is concluded that absolute concentrations of metabolites in vivo yield a different picture of tumor metabolites than that derived from uncorrected metabolite ratios.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8089316     DOI: 10.1097/00004728-199409000-00005

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  16 in total

1.  A study of the relationship of metabolic MR parameters to estrogen dependence in breast cancer xenografts.

Authors:  Ting Liu; Kavindra Nath; Weixia Liu; Rong Zhou; I-Wei Chen
Journal:  NMR Biomed       Date:  2015-07-14       Impact factor: 4.044

2.  Quantification of metabolites from single-voxel in vivo 1H NMR data of normal human brain by means of time-domain data analysis.

Authors:  M Ala-Korpela; J P Usenius; J Keisala; A van den Boogaart; P Vainio; J Jokisaari; S Soimakallio; R Kauppinen
Journal:  MAGMA       Date:  1995 Sep-Dec       Impact factor: 2.310

3.  Regional and developmental variations in metabolite concentration in the rat brain and eye: a study using 1H NMR spectroscopy and high performance liquid chromatography.

Authors:  C L Florian; S R Williams; K K Bhakoo; M D Noble
Journal:  Neurochem Res       Date:  1996-09       Impact factor: 3.996

4.  Preoperative proton MR spectroscopic imaging of brain tumors: correlation with histopathologic analysis of resection specimens.

Authors:  C Dowling; A W Bollen; S M Noworolski; M W McDermott; N M Barbaro; M R Day; R G Henry; S M Chang; W P Dillon; S J Nelson; D B Vigneron
Journal:  AJNR Am J Neuroradiol       Date:  2001-04       Impact factor: 3.825

5.  In vivo characterisation of soft tissue tumours by 1.5-T proton MR spectroscopy.

Authors:  F Russo; S Mazzetti; G Grignani; G De Rosa; M Aglietta; G C Anselmetti; M Stasi; D Regge
Journal:  Eur Radiol       Date:  2011-12-04       Impact factor: 5.315

6.  Proton MR spectroscopy and preoperative diagnostic accuracy: an evaluation of intracranial mass lesions characterized by stereotactic biopsy findings.

Authors:  I M Burtscher; G Skagerberg; B Geijer; E Englund; F Ståhlberg; S Holtås
Journal:  AJNR Am J Neuroradiol       Date:  2000-01       Impact factor: 3.825

7.  Correlation between choline level measured by proton MR spectroscopy and Ki-67 labeling index in gliomas.

Authors:  H Shimizu; T Kumabe; R Shirane; T Yoshimoto
Journal:  AJNR Am J Neuroradiol       Date:  2000-04       Impact factor: 3.825

8.  Potential clinical impact of multiparametric quantitative MR spectroscopy in neurological disorders: A review and analysis.

Authors:  Ivan I Kirov; Assaf Tal
Journal:  Magn Reson Med       Date:  2019-08-08       Impact factor: 4.668

9.  Proton MR spectroscopy of tumefactive demyelinating lesions.

Authors:  Amit M Saindane; Soonmee Cha; Meng Law; Xiaonan Xue; Edmond A Knopp; David Zagzag
Journal:  AJNR Am J Neuroradiol       Date:  2002-09       Impact factor: 3.825

10.  Evaluation of brain tumor metabolism with [11C]choline PET and 1H-MRS.

Authors:  M Utriainen; M Komu; V Vuorinen; P Lehikoinen; P Sonninen; T Kurki; T Utriainen; A Roivainen; H Kalimo; H Minn
Journal:  J Neurooncol       Date:  2003-05       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.